Readystate Asset Management LP Abbott Laboratories Put Options Transaction History

Readystate Asset Management LP

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$100.07 - $118.13 $13.3 Million - $15.8 Million	133,400 Added 2117.46%	139,700 $15.9 Billion
Q2 2024 Aug 14, 2024	SELL	$100.73 - $112.44 $12.5 Million - $14 Million	-124,200 Reduced 95.17%	6,300 $655 Million
Q1 2024 May 10, 2024	BUY	$109.52 - $120.96 $12.2 Million - $13.5 Million	111,300 Added 579.69%	130,500 $14.8 Billion
Q4 2023 Feb 14, 2024	BUY	$90.19 - $110.4 $1.73 Million - $2.12 Million	19,200 New	19,200 $2.11 Billion
Q1 2023 May 15, 2023	BUY	$96.86 - $114.01 $280,894 - $330,629	2,900 New	2,900 $294 Million

3,186

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $202B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Readystate Asset Management LP, based on Form 13F filings with the SEC.

Stay updated on Readystate Asset Management LP with notifications on news.